Regarding PD, enlarged lysosomal morphology is normalised in LRRK2-PD fibroblasts transfected with a siRNA against TPC2 or treated with pharmacological inhibitors of the channel, thus suggesting a detrimental interaction between TPC2 and LRRK2 during the pathology [73]. Here, LRRK2 is linked to Parkinson disease.